T1DM Flashcards

1
Q

T1DM

A

DM is the pathological and metabolic state caused by inadequate insulin action

to be thought of as a vascular disease

selective autoimmune destruction of insulin secreting B cells in the pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

risk of developing T1DM if family have it

A

genetics counts for 1/3 of the risk in T1DM

larger risk in mono and di zygotic twins, HLA identical siblings and if both parents have it

concordance is only 30% in identical twins, indicating environmental influence

(genetics plays a much larger part in T2DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is the genetic risk larger in T1 or T2 DM

A

T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HLA genes

A

represent around half of familial risk

the highest risk genotype is DR3-DQ2/DR4-DQ8

95% of those diangosed with T1DM under the age of 30 have one or both of the genotypes

there is no HLA association in T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the development of T1DM

A
  • there is a genetic predisposition, influenced by foetal risk factors
  • immune dysregulation leads to insulitis and beta cell injury
  • this can lead to pre diabetes, which eventually leads to overt diabetes
  • environmental triggers and factors can accelerate/cause this progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

risk factors in foetal life

A

infection

age

ABO mismatch

birth order

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

auto-immune trigger factors

A

viral infection

vitamin D deficiency

dietary factors

environmental toxins

= pre-diabetes (can last for months to years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

accelerating factors for development of T1DM

A

infection

insulin resistance

puberty

diet/weight

stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diagnosis of DM

A

fasting glucose ≥ 7

random glucose ≥ 11.1

and symptoms of hyperglycaemia OR repeat test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the clinical features of hyperglycaemia

A

hyperglycaemia causes an osmotic diuresis, which causes dehydration: polyuria and polydipsia (excessive thirst)

unexplained weight loss

visual blurring

genital thrush

lethargy and somnolence

increase in appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ensuresis

A

symptom of polyuria due to hyperglycaemia

  • inability to control urination (bed-wetting)

could be a sign of diabetes in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why is there unexplained weight loss

A

insufficient insulin also stops glucose from entering the tissues, meaning they have to break down fats for energy

increased lipolysis (FA release from adipose tissue).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a possible presentation of DM

A

acute short sightedness

later in life develop cataracts, glaucoma etc and diabetic retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why is there visual blurring

A

high levels of glucose in the blood can be absorbed by the lens of the eye, which changes its shape

the lens will return to its normal shape once normal glycaemic control has been established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is lethargy and somnolence associated with

A

poor glycaemic control - go away once this is established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

investigation: urine glucose

A

normally there is no glucose in the urine, if there is too much in the blood it will be excreted via the urine

tested for using urinalysis

17
Q

random glucose

A

not diagnostic of diabetes, ≥11.1 mmol/L

diagnostic with symptoms, resting and fasting raised

OR

fasting and resting raised on 2 separate occasions

18
Q

elevated HbA1c

A

≥48mmol/L

19
Q

HbA1c

A

glycated haemoglobin

during its life a Hb molecules will slowly react and attach (non-enzymatically) to glucose present in the cell - forming glycated Hb

if patient has chronically high blood glucose they will have more HbA1c

used to measure long term blood glucose control in known diabetics as a way of evaluating the effectiveness of their management

20
Q

what is high HbA1c often a sign of

A

non compliance

21
Q

in what situations can HbA1c vary and be unreliable

A

haemolytic anaemia, acute or chronic blood loss, pregnancy

22
Q

describe the limitations of HbA1c

A
23
Q

descibe the target levels for HbA1c

A

normal = 42 mmol/L

pre- diabetes = 42-47 mmol/L

target in diabetic patients = 48 mmol/L in younger patients, 53 mmol/L in others

dangerous = >75 mmol/L

24
Q

islet autoantibodies

A

suggest T1 rather than T2

GAD 65, IA2 and IAA

25
Q

proteinuria

A

sign of kidney damage in diabetes, and could be a sign of hypertension (diabetics are more prone) or diabetic nephropathy

26
Q

what happens to patient’s kidneys when they have poor glycaemic control

A

glycation of the BM of small blood vessels thockens them , in particular the efferent arteriole which stiffens and hardens making it harder for blood to leave the glomerulus

the afferent arteriole dilates allowing more blood into the glomerulus - inc pressure

hyperfiltration

the glomerulus expands and there is thickening of the BM making it more permeable - proteins, eg albumin, are allowed through

= glomerular filtration rate decreases

27
Q

what happens to the cells in the pancreas

A

B cells are destroyed

A (glucagon), D (somatostatin) and PP (pancreatic polypeptide) cells are preserved

28
Q

pathology of pancreas in T1DM

A

active B cell destruction and islets become inflamed - insulitis

infiltrate contains many lymphocytes with a few macrophages

29
Q

pathology of pancreas in T2DM

A

not as much B cell los

amyloid present in islets

30
Q

what are some disease markers of the auto-immune process

A

autoantibodies: GAD65, IA2, IAA

candidate antigens

insulitis

31
Q

what are some disease markers of clinical diabetes

A

lowered insulin, B cell mass and C-peptide

raised glucose

ketones

32
Q

what is expected to happen to insulin secretion

A

after 5 years no endogenous insulin secretion

33
Q

why are is DM seen in CF patients

A

reduced insulin secretion secondary to pancreatic insufficiency